Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

Phase 2/3 Completed Astellas Pharma Inc Ajinomoto USA, INC. · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nateglinide	Small molecule	—	—

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

Summary

Timeline

Drugs

Indications